$MRNA Moderna, Inc. Insider Trading Week 21/2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Moderna, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Moderna, Inc. in week 21/2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 28 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Option Exercise | M | 14.22 | 222,365 | 3,162,030 | 666,044 | |
May 28 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Option Exercise | M | 12.21 | 18,635 | 227,533 | 55,909 | |
May 28 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 51.13 | 241,000 | 12,322,330 | 1,202,510 | 1.4 M to 1.2 M (-16.70 %) |
May 28 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Buy | M | 12.21 | 18,635 | 227,533 | 1,443,510 | 1.4 M to 1.4 M (+1.31 %) |
May 28 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Buy | M | 14.22 | 222,365 | 3,162,030 | 1,424,875 | 1.2 M to 1.4 M (+18.49 %) |
May 28 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Option Exercise | M | 14.22 | 42,570 | 605,345 | 117,980 | |
May 28 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Option Exercise | M | 12.21 | 82,474 | 1,007,008 | 263,760 | |
May 28 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 66.54 | 125,044 | 8,320,428 | 0 | 125 K to 0 (-100.00 %) |
May 28 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Buy | M | 12.21 | 82,474 | 1,007,008 | 125,044 | 42.6 K to 125 K (+193.74 %) |
May 28 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Buy | M | 14.22 | 42,570 | 605,345 | 42,570 | 0 to 42.6 K |
May 28 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 66.11 | 200 | 13,222 | 1,996,540 | 2 M to 2 M (-0.01 %) |
May 28 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 64.94 | 800 | 51,952 | 1,996,740 | 2 M to 2 M (-0.04 %) |
May 28 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 63.97 | 1,000 | 63,970 | 1,997,540 | 2 M to 2 M (-0.05 %) |
May 28 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 62.54 | 1,910 | 119,451 | 1,998,540 | 2 M to 2 M (-0.10 %) |
May 28 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 61.61 | 3,763 | 231,838 | 2,000,450 | 2 M to 2 M (-0.19 %) |
May 28 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 60.77 | 1,182 | 71,830 | 2,004,213 | 2 M to 2 M (-0.06 %) |
May 28 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 58.72 | 100 | 5,872 | 2,005,395 | 2 M to 2 M (0.00 %) |
May 28 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 57.75 | 1,045 | 60,349 | 2,005,495 | 2 M to 2 M (-0.05 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 70.18 | 10,746 | 754,113 | 6,420,766 | 6.4 M to 6.4 M (-0.17 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 69.45 | 69,254 | 4,809,448 | 6,431,512 | 6.5 M to 6.4 M (-1.07 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 70.18 | 56,406 | 3,958,353 | 21,986,399 | 22 M to 22 M (-0.26 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 69.45 | 363,594 | 25,250,331 | 22,042,805 | 22.4 M to 22 M (-1.62 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 72.44 | 367 | 26,584 | 6,500,766 | 6.5 M to 6.5 M (-0.01 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 71.51 | 2,551 | 182,433 | 6,501,133 | 6.5 M to 6.5 M (-0.04 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 70.46 | 3,900 | 274,780 | 6,503,684 | 6.5 M to 6.5 M (-0.06 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 68.81 | 7,443 | 512,185 | 6,507,584 | 6.5 M to 6.5 M (-0.11 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 67.15 | 23,199 | 1,557,822 | 6,515,027 | 6.5 M to 6.5 M (-0.35 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 65.77 | 42,540 | 2,797,690 | 6,538,226 | 6.6 M to 6.5 M (-0.65 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 72.44 | 1,933 | 140,017 | 22,406,399 | 22.4 M to 22.4 M (-0.01 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 71.51 | 13,408 | 958,861 | 22,408,332 | 22.4 M to 22.4 M (-0.06 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 70.46 | 20,492 | 1,443,793 | 22,421,740 | 22.4 M to 22.4 M (-0.09 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 68.81 | 39,082 | 2,689,404 | 22,442,232 | 22.5 M to 22.4 M (-0.17 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 67.15 | 121,771 | 8,176,971 | 22,481,314 | 22.6 M to 22.5 M (-0.54 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 65.77 | 223,314 | 14,686,491 | 22,603,085 | 22.8 M to 22.6 M (-0.98 %) |
May 26 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 70.45 | 28 | 1,973 | 585,454 | 585.5 K to 585.5 K (0.00 %) |
May 26 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 69.69 | 3,277 | 228,374 | 585,482 | 588.8 K to 585.5 K (-0.56 %) |
May 26 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 68.74 | 6,503 | 447,016 | 588,759 | 595.3 K to 588.8 K (-1.09 %) |
May 26 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 67.76 | 1,238 | 83,887 | 595,262 | 596.5 K to 595.3 K (-0.21 %) |